| AXA IM GLOBAL EMERGING MARKETS EQUITY QI B USD ACC | RVI EMERGENTES | 48,51% | 73,09% | 44,94% | 128,58% |
| CLEOME INDEX EUROPE EQUITIES I CAP | RVI EUROPA | 23,33% | 38,72% | 55,65% | 128,58% |
| GAM MULTISTOCK EMERGING MARKETS EQUITY R EUR | RVI EMERGENTES | 52,64% | 64,15% | 28,46% | 128,57% |
| AMUNDI MSCI EMU ESG SELECTION AE CAP | RV EURO | 24,56% | 39,33% | 51,37% | 128,55% |
| SCHRODER GAIA EGERTON EQUITY A1 ACC USD (HEDGED) | GESTIÓN ALTERNATIVA | 13,35% | 54,64% | 56,81% | 128,54% |
| SCHRODER ISF US SMALLER COMPANIES IMPACT C ACC USD | RVI USA SMALL/MID CAP | 22,93% | 28,77% | 25,24% | 128,52% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) SGD | BIOTECNOLOGÍA | 79,50% | 81,71% | 52,92% | 128,47% |
| INVESCO GLOBAL EQUITY INCOME E CAP EUR | RVI GLOBAL | 21,01% | 48,56% | 68,09% | 128,47% |
| POLAR CAPITAL NORTH AMERICAN R GBP DIS HEDGED | RVI USA | 22,52% | 58,74% | 36,95% | 128,46% |
| HSBC GIF ASIA PACIFIC EX JAPAN EQUITY HIGH DIVIDEND EC USD | RVI ASIA EX-JAPÓN | 46,29% | 52,79% | 36,87% | 128,43% |
